plazomicin sulfate (zemdri) Report issue

Small molecule Approved FDA Priority Review FDA
Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now
Plazomicin, sold under the brand name Zemdri, is an aminoglycoside antibiotic used to treat complicated urinary tract infections. As of 2019 it is recommended only for those in whom alternatives are not an option. It is given by injection into a vein.   Wikipedia

Chemistry

  • SMILES: CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O
  • InChIKey: SFTBRKHJMASSAP-BGJNVEJLSA-N
  • Mol. Mass: 690.77
  • ALogP: -5.36
  • ChEMBL Molecule:
    plazomicin sulfate  
More Chemistry

Pharmacology

Alternative names

plazomicin sulfate

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Pyelonephritis

Urinary Tract Infections (approved 2018)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue